These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1197088)

  • 21. Haemostasis parameters behaviour during haemodialysis without anticoagulants.
    Casati S; Moia M; Graziani G; Cantaluppi A; Mannucci PM; Ponticelli C
    Life Support Syst; 1983; 1 Suppl 1():144-7. PubMed ID: 6336396
    [No Abstract]   [Full Text] [Related]  

  • 22. Experiences with peritoneal dialysis in the management of renal failure.
    Singh LM; Gode JD; Agarwal HS; Udupa KN
    J Indian Med Assoc; 1969 Jul; 53(2):59-66. PubMed ID: 5354971
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression of interferon response in lymphocytes from patients with uremia.
    Sanders CV; Luby JP; Sanford JP; Hull AR
    J Lab Clin Med; 1971 May; 77(5):768-76. PubMed ID: 5557663
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum transcortin levels in patients with chronic hemodialysis.
    De Moor P; Faict D; Verberckmoes R
    Ann Biol Clin (Paris); 1985; 43(3):267-9. PubMed ID: 3927790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for hemodialysis and peritoneal dialysis].
    Kessel M
    Dtsch Med J; 1969 Apr; 20(8):233-45. PubMed ID: 5397565
    [No Abstract]   [Full Text] [Related]  

  • 26. [Peritoneal dialysis in the treatment of acute and chronic renal insufficiency].
    Zec J
    Lijec Vjesn; 1967; 89(12):923-35. PubMed ID: 5634088
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of intermittent peritoneal dialysis in the management of renal failure.
    Singh RG; Prakash J; Srivastava PK; Usha
    J Indian Med Assoc; 1984 Jan; 82(1):10-3. PubMed ID: 6747310
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determinative technics of plasma and salivary cortisol in patients with chronic nephropathies in hemodialysis programs].
    Machado CE; Kater CE; Draibe SA; Vieira JG; Chacra AR; Ajzen H
    AMB Rev Assoc Med Bras; 1986; 32(3-4):42-6. PubMed ID: 3024240
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of hemodialysis on hormone levels in preterminal renal failure].
    Bindeballe W; Drenkhahn E; Jüsgen W; Lahrtz H; Leybold K; Niedermayer W; Schemmel K
    Dtsch Med Wochenschr; 1973 Mar; 98(13):661-5. PubMed ID: 4696493
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dialysis treatment of chronic renal failure].
    Thieler H
    Zentralbl Chir; 1993; 118(3):118-21. PubMed ID: 8484283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of renal failure treatment with periteonal dialysis].
    Caban B; Zbikowska A; Kowalewski J; Perlińska-Schnejder L
    Pol Tyg Lek; 1970 Oct; 25(41):1540-2. PubMed ID: 5477042
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
    Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
    Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Continuous peritoneal dialysis in acute kidney failure].
    Biesenbach G; Kramar R
    Wien Med Wochenschr; 1983 Apr; 133(8):191-6. PubMed ID: 6868617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino nitrogen loss during haemodialysis, its dietary significance and replacement.
    Young GA; Parsons FM
    Clin Sci; 1966 Oct; 31(2):299-307. PubMed ID: 5955726
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum transcobalamin II levels in patients with acute and chronic renal failure.
    Areekul S; Churdchu K; Cheeramakara C; Wilairatana P; Charoenlarp P
    J Med Assoc Thai; 1995 Apr; 78(4):191-6. PubMed ID: 7673805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal insufficiency and hemostasis].
    Nieth H
    Thromb Diath Haemorrh; 1968; ():141-54. PubMed ID: 5726650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.